Lupin has provided an update on its acquisition of Nanomi B.V.’s subsidiary, VISUfarma B.V., headquartered in Amsterdam. The company now anticipates completing the transaction by February 28, 2026, subject to certain closing conditions. This follows an earlier announcement indicating a completion target by the end of calendar year 2025.
VISUfarma Acquisition Progress
Lupin previously announced an agreement to acquire VISUfarma B.V., a subsidiary of Nanomi B.V. This strategic move is aimed at expanding Lupin’s presence in the European market. The company has updated the expected completion date for this acquisition.
Revised Completion Timeline
According to the latest update, the proposed transaction is currently progressing as planned. Lupin now expects to finalize the acquisition of VISUfarma B.V. by February 28, 2026. This revised timeline is subject to the fulfillment of certain customary closing conditions. The initial announcement indicated that the transaction was expected to be completed by the end of calendar year 2025.
Source: BSE
